<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The occurrence of strains resistant to <z:chebi fb="1" ids="6909">metronidazole</z:chebi> is causing failure of the 4-drug regimen for eradication of Helicobacter pylori in the Islamic Republic of Iran </plain></SENT>
<SENT sid="1" pm="."><plain>This study compared the in vitro efficacy of <z:chebi fb="0" ids="5195">furazolidone</z:chebi> with <z:chebi fb="1" ids="6909">metronidazole</z:chebi>, clarithromycin, <z:chebi fb="0" ids="2676">amoxicillin</z:chebi> and <z:chebi fb="9" ids="27902">tetracycline</z:chebi> in 70 H. pylori isolates from dyspeptic patients </plain></SENT>
<SENT sid="2" pm="."><plain>Of the isolates, 33% were resistant to <z:chebi fb="1" ids="6909">metronidazole</z:chebi> but <z:hpo ids='HP_0000001'>all</z:hpo> were susceptible to <z:chebi fb="0" ids="5195">furazolidone</z:chebi> </plain></SENT>
<SENT sid="3" pm="."><plain><z:chebi fb="0" ids="5195">Furazolidone</z:chebi> could be considered as an appropriate substitute for <z:chebi fb="1" ids="6909">metronidazole</z:chebi> for H. pylori <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infections</z:e> </plain></SENT>
</text></document>